Global NGS-based RNA-seq Supply, Demand and Key Producers, 2026-2032
The global NGS-based RNA-seq market size is expected to reach $ 7957 million by 2032, rising at a market growth of 10.6% CAGR during the forecast period (2026-2032).
The gross profit margin of major companies in the industry was approximately 45%–70%.
NGS-based RNA Sequencing is a molecular analysis technology that uses next-generation sequencing to identify, quantify, and characterize RNA molecules, enabling analysis of gene expression, transcript structures, and biological variation. Products and services mainly include RNA sequencing workflows, sequencing reagents, library preparation solutions, and sequencing services for scientific research, drug development, clinical research, biotechnology, agriculture, and precision medicine.
The industrial chain of NGS-based RNA Sequencing includes upstream sequencing reagents, library preparation materials, sequencing instruments, laboratory consumables, and bioinformatics technologies; midstream covers sample processing, library construction, sequencing, quality control, and data analysis; downstream applications mainly include academic research, pharmaceutical development, clinical research, biotechnology, agriculture, and precision medicine.
NGS-based RNA sequencing is a high-throughput molecular analysis approach that uses next-generation sequencing technologies to characterize RNA molecules, enabling comprehensive analysis of gene expression, transcript structures, alternative splicing, gene fusions, and other transcriptomic features. It is widely applied in basic biological research, oncology, drug discovery and development, biomarker research, precision medicine, and other life science applications. Compared with conventional targeted expression analysis methods, NGS-based RNA sequencing provides broader transcriptome coverage and greater capability to identify previously unknown transcripts and molecular changes. Market development is being driven by continued advances in sequencing platforms, library preparation, bioinformatics, and computational analysis, which are improving throughput, sensitivity, reproducibility, and workflow efficiency. Growing investment in genomics and transcriptomics research, expanding cancer and rare disease studies, increasing pharmaceutical research activity, and rising demand for precision medicine are supporting broader adoption. Important opportunities are emerging from single-cell and spatial transcriptomics, liquid biopsy research, clinical biomarker development, immune profiling, and integration of RNA sequencing with genomics, proteomics, and other multi-omics approaches. Increasing automation of sample preparation and data analysis may further improve accessibility across research and clinical laboratories. However, market development remains constrained by sequencing and computational costs, complex sample preparation, large data processing requirements, challenges in standardizing analytical workflows, and the need for specialized bioinformatics expertise. Clinical adoption also requires robust validation, reproducibility, and compliance with regulatory requirements. Continued improvements in sequencing efficiency, analytical software, automation, and cost effectiveness are expected to expand the role of NGS-based RNA sequencing in biomedical research and selected clinical applications.
This report is a detailed and comprehensive analysis of the world market for NGS-based RNA-seq, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of NGS-based RNA-seq that contribute to its increasing demand across many markets.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world NGS-based RNA-seq market
2. What is the demand of the global NGS-based RNA-seq market?
3. What is the year over year growth of the global NGS-based RNA-seq market?
4. What is the total value of the global NGS-based RNA-seq market?
5. Who are the Major Players in the global NGS-based RNA-seq market?
6. What are the growth factors driving the market demand?
The gross profit margin of major companies in the industry was approximately 45%–70%.
NGS-based RNA Sequencing is a molecular analysis technology that uses next-generation sequencing to identify, quantify, and characterize RNA molecules, enabling analysis of gene expression, transcript structures, and biological variation. Products and services mainly include RNA sequencing workflows, sequencing reagents, library preparation solutions, and sequencing services for scientific research, drug development, clinical research, biotechnology, agriculture, and precision medicine.
The industrial chain of NGS-based RNA Sequencing includes upstream sequencing reagents, library preparation materials, sequencing instruments, laboratory consumables, and bioinformatics technologies; midstream covers sample processing, library construction, sequencing, quality control, and data analysis; downstream applications mainly include academic research, pharmaceutical development, clinical research, biotechnology, agriculture, and precision medicine.
NGS-based RNA sequencing is a high-throughput molecular analysis approach that uses next-generation sequencing technologies to characterize RNA molecules, enabling comprehensive analysis of gene expression, transcript structures, alternative splicing, gene fusions, and other transcriptomic features. It is widely applied in basic biological research, oncology, drug discovery and development, biomarker research, precision medicine, and other life science applications. Compared with conventional targeted expression analysis methods, NGS-based RNA sequencing provides broader transcriptome coverage and greater capability to identify previously unknown transcripts and molecular changes. Market development is being driven by continued advances in sequencing platforms, library preparation, bioinformatics, and computational analysis, which are improving throughput, sensitivity, reproducibility, and workflow efficiency. Growing investment in genomics and transcriptomics research, expanding cancer and rare disease studies, increasing pharmaceutical research activity, and rising demand for precision medicine are supporting broader adoption. Important opportunities are emerging from single-cell and spatial transcriptomics, liquid biopsy research, clinical biomarker development, immune profiling, and integration of RNA sequencing with genomics, proteomics, and other multi-omics approaches. Increasing automation of sample preparation and data analysis may further improve accessibility across research and clinical laboratories. However, market development remains constrained by sequencing and computational costs, complex sample preparation, large data processing requirements, challenges in standardizing analytical workflows, and the need for specialized bioinformatics expertise. Clinical adoption also requires robust validation, reproducibility, and compliance with regulatory requirements. Continued improvements in sequencing efficiency, analytical software, automation, and cost effectiveness are expected to expand the role of NGS-based RNA sequencing in biomedical research and selected clinical applications.
Report Scope
This report studies the global NGS-based RNA-seq demand, key companies, and key regions.This report is a detailed and comprehensive analysis of the world market for NGS-based RNA-seq, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of NGS-based RNA-seq that contribute to its increasing demand across many markets.
Highlights and key features of the study
- Global NGS-based RNA-seq total market, 2021-2032, (USD Million)
- Global NGS-based RNA-seq total market by region & country, CAGR, 2021-2032, (USD Million)
- U.S. VS China: NGS-based RNA-seq total market, key domestic companies, and share, (USD Million)
- Global NGS-based RNA-seq revenue by player, revenue and market share 2021-2026, (USD Million)
- Global NGS-based RNA-seq total market by Type, CAGR, 2021-2032, (USD Million)
- Global NGS-based RNA-seq total market by Application, CAGR, 2021-2032, (USD Million)
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world NGS-based RNA-seq market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.Global NGS-based RNA-seq Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
Market Segmentation
Global NGS-based RNA-seq Market, Segmentation by Type:
- Whole Transcriptome Sequencing
- Targeted RNA Sequencing
- Small RNA Sequencing
Global NGS-based RNA-seq Market, Segmentation by Library Preparation Method:
- Poly(A) Enrichment-based Sequencing
- rRNA Depletion-based Sequencing
- Capture and Amplicon-based Sequencing
Global NGS-based RNA-seq Market, Segmentation by Sequencing Depth per Sample:
- Low-depth(≤20 Million Reads)
- Medium-depth(>20–100 Million Reads)
- High-depth(>100 Million Reads)
Global NGS-based RNA-seq Market, Segmentation by Application:
- Gene Expression Profiling
- Biomarker and Disease Research
- Fusion, Splicing and Transcript Variant Analysis
- Other
Companies Profiled:
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- QIAGEN N.V.
- Takara Bio Inc.
- Azenta, Inc.
- Eurofins Scientific SE
- BGI Americas Corporation
- Macrogen, Inc.
- Ebiogen Inc.
- Theragen Bio Co., Ltd.
- Psomagen, Inc.
- GeneMotions Co., Ltd.
- BGI Genomics Co., Ltd.
- MGI Tech Co., Ltd.
- Novogene Co., Ltd.
- Annoroad Gene Technology Co., Ltd.
- Shanghai OE Biotech Co., Ltd.
- LC-Bio Technology Co., Ltd.
- Guangzhou Gene Denovo Biotechnology Co., Ltd.
- Biomarker Technologies Corporation
- Berry Genomics Co., Ltd.
- CapitalBio Technology Co., Ltd.
Key Questions Answered
1. How big is the global NGS-based RNA-seq market?2. What is the demand of the global NGS-based RNA-seq market?
3. What is the year over year growth of the global NGS-based RNA-seq market?
4. What is the total value of the global NGS-based RNA-seq market?
5. Who are the Major Players in the global NGS-based RNA-seq market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 NGS-based RNA-seq Introduction
1.2 World NGS-based RNA-seq Market Size & Forecast (2021 & 2025 & 2032)
1.3 World NGS-based RNA-seq Total Market by Region (by Headquarter Location)
1.3.1 World NGS-based RNA-seq Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company NGS-based RNA-seq Revenue (2021-2032)
1.3.3 China Based Company NGS-based RNA-seq Revenue (2021-2032)
1.3.4 Europe Based Company NGS-based RNA-seq Revenue (2021-2032)
1.3.5 Japan Based Company NGS-based RNA-seq Revenue (2021-2032)
1.3.6 South Korea Based Company NGS-based RNA-seq Revenue (2021-2032)
1.3.7 ASEAN Based Company NGS-based RNA-seq Revenue (2021-2032)
1.3.8 India Based Company NGS-based RNA-seq Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 NGS-based RNA-seq Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World NGS-based RNA-seq Consumption Value (2021-2032)
2.2 World NGS-based RNA-seq Consumption Value by Region
2.2.1 World NGS-based RNA-seq Consumption Value by Region (2021-2026)
2.2.2 World NGS-based RNA-seq Consumption Value Forecast by Region (2027-2032)
2.3 United States NGS-based RNA-seq Consumption Value (2021-2032)
2.4 China NGS-based RNA-seq Consumption Value (2021-2032)
2.5 Europe NGS-based RNA-seq Consumption Value (2021-2032)
2.6 Japan NGS-based RNA-seq Consumption Value (2021-2032)
2.7 South Korea NGS-based RNA-seq Consumption Value (2021-2032)
2.8 ASEAN NGS-based RNA-seq Consumption Value (2021-2032)
2.9 India NGS-based RNA-seq Consumption Value (2021-2032)
3 WORLD NGS-BASED RNA-SEQ COMPANIES COMPETITIVE ANALYSIS
3.1 World NGS-based RNA-seq Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global NGS-based RNA-seq Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for NGS-based RNA-seq in 2025
3.2.3 Global Concentration Ratios (CR8) for NGS-based RNA-seq in 2025
3.3 NGS-based RNA-seq Company Evaluation Quadrant
3.4 NGS-based RNA-seq Market: Overall Company Footprint Analysis
3.4.1 NGS-based RNA-seq Market: Region Footprint
3.4.2 NGS-based RNA-seq Market: Company Product Type Footprint
3.4.3 NGS-based RNA-seq Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: NGS-based RNA-seq Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: NGS-based RNA-seq Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: NGS-based RNA-seq Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: NGS-based RNA-seq Consumption Value Comparison
4.2.1 United States VS China: NGS-based RNA-seq Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: NGS-based RNA-seq Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based NGS-based RNA-seq Companies and Market Share, 2021-2026
4.3.1 United States Based NGS-based RNA-seq Companies, Headquarters (States, Country)
4.3.2 United States Based Companies NGS-based RNA-seq Revenue, (2021-2026)
4.4 China Based Companies NGS-based RNA-seq Revenue and Market Share, 2021-2026
4.4.1 China Based NGS-based RNA-seq Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies NGS-based RNA-seq Revenue, (2021-2026)
4.5 Rest of World Based NGS-based RNA-seq Companies and Market Share, 2021-2026
4.5.1 Rest of World Based NGS-based RNA-seq Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies NGS-based RNA-seq Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World NGS-based RNA-seq Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Whole Transcriptome Sequencing
5.2.2 Targeted RNA Sequencing
5.2.3 Small RNA Sequencing
5.3 Market Segment by Type
5.3.1 World NGS-based RNA-seq Market Size by Type (2021-2026)
5.3.2 World NGS-based RNA-seq Market Size by Type (2027-2032)
5.3.3 World NGS-based RNA-seq Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY LIBRARY PREPARATION METHOD
6.1 World NGS-based RNA-seq Market Size Overview by Library Preparation Method: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Library Preparation Method
6.2.1 Poly(A) Enrichment-based Sequencing
6.2.2 rRNA Depletion-based Sequencing
6.2.3 Capture and Amplicon-based Sequencing
6.3 Market Segment by Library Preparation Method
6.3.1 World NGS-based RNA-seq Market Size by Library Preparation Method (2021-2026)
6.3.2 World NGS-based RNA-seq Market Size by Library Preparation Method (2027-2032)
6.3.3 World NGS-based RNA-seq Market Size Market Share by Library Preparation Method (2027-2032)
7 MARKET ANALYSIS BY SEQUENCING DEPTH PER SAMPLE
7.1 World NGS-based RNA-seq Market Size Overview by Sequencing Depth per Sample: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Sequencing Depth per Sample
7.2.1 Low-depth(≤20 Million Reads)
7.2.2 Medium-depth(>20–100 Million Reads)
7.2.3 High-depth(>100 Million Reads)
7.3 Market Segment by Sequencing Depth per Sample
7.3.1 World NGS-based RNA-seq Market Size by Sequencing Depth per Sample (2021-2026)
7.3.2 World NGS-based RNA-seq Market Size by Sequencing Depth per Sample (2027-2032)
7.3.3 World NGS-based RNA-seq Market Size Market Share by Sequencing Depth per Sample (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World NGS-based RNA-seq Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Gene Expression Profiling
8.2.2 Biomarker and Disease Research
8.2.3 Fusion, Splicing and Transcript Variant Analysis
8.2.4 Other
8.3 Market Segment by Application
8.3.1 World NGS-based RNA-seq Market Size by Application (2021-2026)
8.3.2 World NGS-based RNA-seq Market Size by Application (2027-2032)
8.3.3 World NGS-based RNA-seq Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Illumina, Inc.
9.1.1 Illumina, Inc. Details
9.1.2 Illumina, Inc. Major Business
9.1.3 Illumina, Inc. NGS-based RNA-seq Product and Services
9.1.4 Illumina, Inc. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Illumina, Inc. Recent Developments/Updates
9.1.6 Illumina, Inc. Competitive Strengths & Weaknesses
9.2 Thermo Fisher Scientific Inc.
9.2.1 Thermo Fisher Scientific Inc. Details
9.2.2 Thermo Fisher Scientific Inc. Major Business
9.2.3 Thermo Fisher Scientific Inc. NGS-based RNA-seq Product and Services
9.2.4 Thermo Fisher Scientific Inc. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
9.2.6 Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
9.3 QIAGEN N.V.
9.3.1 QIAGEN N.V. Details
9.3.2 QIAGEN N.V. Major Business
9.3.3 QIAGEN N.V. NGS-based RNA-seq Product and Services
9.3.4 QIAGEN N.V. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 QIAGEN N.V. Recent Developments/Updates
9.3.6 QIAGEN N.V. Competitive Strengths & Weaknesses
9.4 Takara Bio Inc.
9.4.1 Takara Bio Inc. Details
9.4.2 Takara Bio Inc. Major Business
9.4.3 Takara Bio Inc. NGS-based RNA-seq Product and Services
9.4.4 Takara Bio Inc. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Takara Bio Inc. Recent Developments/Updates
9.4.6 Takara Bio Inc. Competitive Strengths & Weaknesses
9.5 Azenta, Inc.
9.5.1 Azenta, Inc. Details
9.5.2 Azenta, Inc. Major Business
9.5.3 Azenta, Inc. NGS-based RNA-seq Product and Services
9.5.4 Azenta, Inc. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Azenta, Inc. Recent Developments/Updates
9.5.6 Azenta, Inc. Competitive Strengths & Weaknesses
9.6 Eurofins Scientific SE
9.6.1 Eurofins Scientific SE Details
9.6.2 Eurofins Scientific SE Major Business
9.6.3 Eurofins Scientific SE NGS-based RNA-seq Product and Services
9.6.4 Eurofins Scientific SE NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Eurofins Scientific SE Recent Developments/Updates
9.6.6 Eurofins Scientific SE Competitive Strengths & Weaknesses
9.7 BGI Americas Corporation
9.7.1 BGI Americas Corporation Details
9.7.2 BGI Americas Corporation Major Business
9.7.3 BGI Americas Corporation NGS-based RNA-seq Product and Services
9.7.4 BGI Americas Corporation NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 BGI Americas Corporation Recent Developments/Updates
9.7.6 BGI Americas Corporation Competitive Strengths & Weaknesses
9.8 Macrogen, Inc.
9.8.1 Macrogen, Inc. Details
9.8.2 Macrogen, Inc. Major Business
9.8.3 Macrogen, Inc. NGS-based RNA-seq Product and Services
9.8.4 Macrogen, Inc. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Macrogen, Inc. Recent Developments/Updates
9.8.6 Macrogen, Inc. Competitive Strengths & Weaknesses
9.9 Ebiogen Inc.
9.9.1 Ebiogen Inc. Details
9.9.2 Ebiogen Inc. Major Business
9.9.3 Ebiogen Inc. NGS-based RNA-seq Product and Services
9.9.4 Ebiogen Inc. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Ebiogen Inc. Recent Developments/Updates
9.9.6 Ebiogen Inc. Competitive Strengths & Weaknesses
9.10 Theragen Bio Co., Ltd.
9.10.1 Theragen Bio Co., Ltd. Details
9.10.2 Theragen Bio Co., Ltd. Major Business
9.10.3 Theragen Bio Co., Ltd. NGS-based RNA-seq Product and Services
9.10.4 Theragen Bio Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Theragen Bio Co., Ltd. Recent Developments/Updates
9.10.6 Theragen Bio Co., Ltd. Competitive Strengths & Weaknesses
9.11 Psomagen, Inc.
9.11.1 Psomagen, Inc. Details
9.11.2 Psomagen, Inc. Major Business
9.11.3 Psomagen, Inc. NGS-based RNA-seq Product and Services
9.11.4 Psomagen, Inc. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Psomagen, Inc. Recent Developments/Updates
9.11.6 Psomagen, Inc. Competitive Strengths & Weaknesses
9.12 GeneMotions Co., Ltd.
9.12.1 GeneMotions Co., Ltd. Details
9.12.2 GeneMotions Co., Ltd. Major Business
9.12.3 GeneMotions Co., Ltd. NGS-based RNA-seq Product and Services
9.12.4 GeneMotions Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 GeneMotions Co., Ltd. Recent Developments/Updates
9.12.6 GeneMotions Co., Ltd. Competitive Strengths & Weaknesses
9.13 BGI Genomics Co., Ltd.
9.13.1 BGI Genomics Co., Ltd. Details
9.13.2 BGI Genomics Co., Ltd. Major Business
9.13.3 BGI Genomics Co., Ltd. NGS-based RNA-seq Product and Services
9.13.4 BGI Genomics Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 BGI Genomics Co., Ltd. Recent Developments/Updates
9.13.6 BGI Genomics Co., Ltd. Competitive Strengths & Weaknesses
9.14 MGI Tech Co., Ltd.
9.14.1 MGI Tech Co., Ltd. Details
9.14.2 MGI Tech Co., Ltd. Major Business
9.14.3 MGI Tech Co., Ltd. NGS-based RNA-seq Product and Services
9.14.4 MGI Tech Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 MGI Tech Co., Ltd. Recent Developments/Updates
9.14.6 MGI Tech Co., Ltd. Competitive Strengths & Weaknesses
9.15 Novogene Co., Ltd.
9.15.1 Novogene Co., Ltd. Details
9.15.2 Novogene Co., Ltd. Major Business
9.15.3 Novogene Co., Ltd. NGS-based RNA-seq Product and Services
9.15.4 Novogene Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Novogene Co., Ltd. Recent Developments/Updates
9.15.6 Novogene Co., Ltd. Competitive Strengths & Weaknesses
9.16 Annoroad Gene Technology Co., Ltd.
9.16.1 Annoroad Gene Technology Co., Ltd. Details
9.16.2 Annoroad Gene Technology Co., Ltd. Major Business
9.16.3 Annoroad Gene Technology Co., Ltd. NGS-based RNA-seq Product and Services
9.16.4 Annoroad Gene Technology Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Annoroad Gene Technology Co., Ltd. Recent Developments/Updates
9.16.6 Annoroad Gene Technology Co., Ltd. Competitive Strengths & Weaknesses
9.17 Shanghai OE Biotech Co., Ltd.
9.17.1 Shanghai OE Biotech Co., Ltd. Details
9.17.2 Shanghai OE Biotech Co., Ltd. Major Business
9.17.3 Shanghai OE Biotech Co., Ltd. NGS-based RNA-seq Product and Services
9.17.4 Shanghai OE Biotech Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Shanghai OE Biotech Co., Ltd. Recent Developments/Updates
9.17.6 Shanghai OE Biotech Co., Ltd. Competitive Strengths & Weaknesses
9.18 LC-Bio Technology Co., Ltd.
9.18.1 LC-Bio Technology Co., Ltd. Details
9.18.2 LC-Bio Technology Co., Ltd. Major Business
9.18.3 LC-Bio Technology Co., Ltd. NGS-based RNA-seq Product and Services
9.18.4 LC-Bio Technology Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 LC-Bio Technology Co., Ltd. Recent Developments/Updates
9.18.6 LC-Bio Technology Co., Ltd. Competitive Strengths & Weaknesses
9.19 Guangzhou Gene Denovo Biotechnology Co., Ltd.
9.19.1 Guangzhou Gene Denovo Biotechnology Co., Ltd. Details
9.19.2 Guangzhou Gene Denovo Biotechnology Co., Ltd. Major Business
9.19.3 Guangzhou Gene Denovo Biotechnology Co., Ltd. NGS-based RNA-seq Product and Services
9.19.4 Guangzhou Gene Denovo Biotechnology Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Guangzhou Gene Denovo Biotechnology Co., Ltd. Recent Developments/Updates
9.19.6 Guangzhou Gene Denovo Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
9.20 Biomarker Technologies Corporation
9.20.1 Biomarker Technologies Corporation Details
9.20.2 Biomarker Technologies Corporation Major Business
9.20.3 Biomarker Technologies Corporation NGS-based RNA-seq Product and Services
9.20.4 Biomarker Technologies Corporation NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 Biomarker Technologies Corporation Recent Developments/Updates
9.20.6 Biomarker Technologies Corporation Competitive Strengths & Weaknesses
9.21 Berry Genomics Co., Ltd.
9.21.1 Berry Genomics Co., Ltd. Details
9.21.2 Berry Genomics Co., Ltd. Major Business
9.21.3 Berry Genomics Co., Ltd. NGS-based RNA-seq Product and Services
9.21.4 Berry Genomics Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 Berry Genomics Co., Ltd. Recent Developments/Updates
9.21.6 Berry Genomics Co., Ltd. Competitive Strengths & Weaknesses
9.22 CapitalBio Technology Co., Ltd.
9.22.1 CapitalBio Technology Co., Ltd. Details
9.22.2 CapitalBio Technology Co., Ltd. Major Business
9.22.3 CapitalBio Technology Co., Ltd. NGS-based RNA-seq Product and Services
9.22.4 CapitalBio Technology Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 CapitalBio Technology Co., Ltd. Recent Developments/Updates
9.22.6 CapitalBio Technology Co., Ltd. Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 NGS-based RNA-seq Industry Chain
10.2 NGS-based RNA-seq Upstream Analysis
10.3 NGS-based RNA-seq Midstream Analysis
10.4 NGS-based RNA-seq Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 NGS-based RNA-seq Introduction
1.2 World NGS-based RNA-seq Market Size & Forecast (2021 & 2025 & 2032)
1.3 World NGS-based RNA-seq Total Market by Region (by Headquarter Location)
1.3.1 World NGS-based RNA-seq Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company NGS-based RNA-seq Revenue (2021-2032)
1.3.3 China Based Company NGS-based RNA-seq Revenue (2021-2032)
1.3.4 Europe Based Company NGS-based RNA-seq Revenue (2021-2032)
1.3.5 Japan Based Company NGS-based RNA-seq Revenue (2021-2032)
1.3.6 South Korea Based Company NGS-based RNA-seq Revenue (2021-2032)
1.3.7 ASEAN Based Company NGS-based RNA-seq Revenue (2021-2032)
1.3.8 India Based Company NGS-based RNA-seq Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 NGS-based RNA-seq Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World NGS-based RNA-seq Consumption Value (2021-2032)
2.2 World NGS-based RNA-seq Consumption Value by Region
2.2.1 World NGS-based RNA-seq Consumption Value by Region (2021-2026)
2.2.2 World NGS-based RNA-seq Consumption Value Forecast by Region (2027-2032)
2.3 United States NGS-based RNA-seq Consumption Value (2021-2032)
2.4 China NGS-based RNA-seq Consumption Value (2021-2032)
2.5 Europe NGS-based RNA-seq Consumption Value (2021-2032)
2.6 Japan NGS-based RNA-seq Consumption Value (2021-2032)
2.7 South Korea NGS-based RNA-seq Consumption Value (2021-2032)
2.8 ASEAN NGS-based RNA-seq Consumption Value (2021-2032)
2.9 India NGS-based RNA-seq Consumption Value (2021-2032)
3 WORLD NGS-BASED RNA-SEQ COMPANIES COMPETITIVE ANALYSIS
3.1 World NGS-based RNA-seq Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global NGS-based RNA-seq Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for NGS-based RNA-seq in 2025
3.2.3 Global Concentration Ratios (CR8) for NGS-based RNA-seq in 2025
3.3 NGS-based RNA-seq Company Evaluation Quadrant
3.4 NGS-based RNA-seq Market: Overall Company Footprint Analysis
3.4.1 NGS-based RNA-seq Market: Region Footprint
3.4.2 NGS-based RNA-seq Market: Company Product Type Footprint
3.4.3 NGS-based RNA-seq Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: NGS-based RNA-seq Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: NGS-based RNA-seq Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: NGS-based RNA-seq Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: NGS-based RNA-seq Consumption Value Comparison
4.2.1 United States VS China: NGS-based RNA-seq Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: NGS-based RNA-seq Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based NGS-based RNA-seq Companies and Market Share, 2021-2026
4.3.1 United States Based NGS-based RNA-seq Companies, Headquarters (States, Country)
4.3.2 United States Based Companies NGS-based RNA-seq Revenue, (2021-2026)
4.4 China Based Companies NGS-based RNA-seq Revenue and Market Share, 2021-2026
4.4.1 China Based NGS-based RNA-seq Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies NGS-based RNA-seq Revenue, (2021-2026)
4.5 Rest of World Based NGS-based RNA-seq Companies and Market Share, 2021-2026
4.5.1 Rest of World Based NGS-based RNA-seq Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies NGS-based RNA-seq Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World NGS-based RNA-seq Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Whole Transcriptome Sequencing
5.2.2 Targeted RNA Sequencing
5.2.3 Small RNA Sequencing
5.3 Market Segment by Type
5.3.1 World NGS-based RNA-seq Market Size by Type (2021-2026)
5.3.2 World NGS-based RNA-seq Market Size by Type (2027-2032)
5.3.3 World NGS-based RNA-seq Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY LIBRARY PREPARATION METHOD
6.1 World NGS-based RNA-seq Market Size Overview by Library Preparation Method: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Library Preparation Method
6.2.1 Poly(A) Enrichment-based Sequencing
6.2.2 rRNA Depletion-based Sequencing
6.2.3 Capture and Amplicon-based Sequencing
6.3 Market Segment by Library Preparation Method
6.3.1 World NGS-based RNA-seq Market Size by Library Preparation Method (2021-2026)
6.3.2 World NGS-based RNA-seq Market Size by Library Preparation Method (2027-2032)
6.3.3 World NGS-based RNA-seq Market Size Market Share by Library Preparation Method (2027-2032)
7 MARKET ANALYSIS BY SEQUENCING DEPTH PER SAMPLE
7.1 World NGS-based RNA-seq Market Size Overview by Sequencing Depth per Sample: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Sequencing Depth per Sample
7.2.1 Low-depth(≤20 Million Reads)
7.2.2 Medium-depth(>20–100 Million Reads)
7.2.3 High-depth(>100 Million Reads)
7.3 Market Segment by Sequencing Depth per Sample
7.3.1 World NGS-based RNA-seq Market Size by Sequencing Depth per Sample (2021-2026)
7.3.2 World NGS-based RNA-seq Market Size by Sequencing Depth per Sample (2027-2032)
7.3.3 World NGS-based RNA-seq Market Size Market Share by Sequencing Depth per Sample (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World NGS-based RNA-seq Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Gene Expression Profiling
8.2.2 Biomarker and Disease Research
8.2.3 Fusion, Splicing and Transcript Variant Analysis
8.2.4 Other
8.3 Market Segment by Application
8.3.1 World NGS-based RNA-seq Market Size by Application (2021-2026)
8.3.2 World NGS-based RNA-seq Market Size by Application (2027-2032)
8.3.3 World NGS-based RNA-seq Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Illumina, Inc.
9.1.1 Illumina, Inc. Details
9.1.2 Illumina, Inc. Major Business
9.1.3 Illumina, Inc. NGS-based RNA-seq Product and Services
9.1.4 Illumina, Inc. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Illumina, Inc. Recent Developments/Updates
9.1.6 Illumina, Inc. Competitive Strengths & Weaknesses
9.2 Thermo Fisher Scientific Inc.
9.2.1 Thermo Fisher Scientific Inc. Details
9.2.2 Thermo Fisher Scientific Inc. Major Business
9.2.3 Thermo Fisher Scientific Inc. NGS-based RNA-seq Product and Services
9.2.4 Thermo Fisher Scientific Inc. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
9.2.6 Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
9.3 QIAGEN N.V.
9.3.1 QIAGEN N.V. Details
9.3.2 QIAGEN N.V. Major Business
9.3.3 QIAGEN N.V. NGS-based RNA-seq Product and Services
9.3.4 QIAGEN N.V. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 QIAGEN N.V. Recent Developments/Updates
9.3.6 QIAGEN N.V. Competitive Strengths & Weaknesses
9.4 Takara Bio Inc.
9.4.1 Takara Bio Inc. Details
9.4.2 Takara Bio Inc. Major Business
9.4.3 Takara Bio Inc. NGS-based RNA-seq Product and Services
9.4.4 Takara Bio Inc. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Takara Bio Inc. Recent Developments/Updates
9.4.6 Takara Bio Inc. Competitive Strengths & Weaknesses
9.5 Azenta, Inc.
9.5.1 Azenta, Inc. Details
9.5.2 Azenta, Inc. Major Business
9.5.3 Azenta, Inc. NGS-based RNA-seq Product and Services
9.5.4 Azenta, Inc. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Azenta, Inc. Recent Developments/Updates
9.5.6 Azenta, Inc. Competitive Strengths & Weaknesses
9.6 Eurofins Scientific SE
9.6.1 Eurofins Scientific SE Details
9.6.2 Eurofins Scientific SE Major Business
9.6.3 Eurofins Scientific SE NGS-based RNA-seq Product and Services
9.6.4 Eurofins Scientific SE NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Eurofins Scientific SE Recent Developments/Updates
9.6.6 Eurofins Scientific SE Competitive Strengths & Weaknesses
9.7 BGI Americas Corporation
9.7.1 BGI Americas Corporation Details
9.7.2 BGI Americas Corporation Major Business
9.7.3 BGI Americas Corporation NGS-based RNA-seq Product and Services
9.7.4 BGI Americas Corporation NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 BGI Americas Corporation Recent Developments/Updates
9.7.6 BGI Americas Corporation Competitive Strengths & Weaknesses
9.8 Macrogen, Inc.
9.8.1 Macrogen, Inc. Details
9.8.2 Macrogen, Inc. Major Business
9.8.3 Macrogen, Inc. NGS-based RNA-seq Product and Services
9.8.4 Macrogen, Inc. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Macrogen, Inc. Recent Developments/Updates
9.8.6 Macrogen, Inc. Competitive Strengths & Weaknesses
9.9 Ebiogen Inc.
9.9.1 Ebiogen Inc. Details
9.9.2 Ebiogen Inc. Major Business
9.9.3 Ebiogen Inc. NGS-based RNA-seq Product and Services
9.9.4 Ebiogen Inc. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Ebiogen Inc. Recent Developments/Updates
9.9.6 Ebiogen Inc. Competitive Strengths & Weaknesses
9.10 Theragen Bio Co., Ltd.
9.10.1 Theragen Bio Co., Ltd. Details
9.10.2 Theragen Bio Co., Ltd. Major Business
9.10.3 Theragen Bio Co., Ltd. NGS-based RNA-seq Product and Services
9.10.4 Theragen Bio Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Theragen Bio Co., Ltd. Recent Developments/Updates
9.10.6 Theragen Bio Co., Ltd. Competitive Strengths & Weaknesses
9.11 Psomagen, Inc.
9.11.1 Psomagen, Inc. Details
9.11.2 Psomagen, Inc. Major Business
9.11.3 Psomagen, Inc. NGS-based RNA-seq Product and Services
9.11.4 Psomagen, Inc. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Psomagen, Inc. Recent Developments/Updates
9.11.6 Psomagen, Inc. Competitive Strengths & Weaknesses
9.12 GeneMotions Co., Ltd.
9.12.1 GeneMotions Co., Ltd. Details
9.12.2 GeneMotions Co., Ltd. Major Business
9.12.3 GeneMotions Co., Ltd. NGS-based RNA-seq Product and Services
9.12.4 GeneMotions Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 GeneMotions Co., Ltd. Recent Developments/Updates
9.12.6 GeneMotions Co., Ltd. Competitive Strengths & Weaknesses
9.13 BGI Genomics Co., Ltd.
9.13.1 BGI Genomics Co., Ltd. Details
9.13.2 BGI Genomics Co., Ltd. Major Business
9.13.3 BGI Genomics Co., Ltd. NGS-based RNA-seq Product and Services
9.13.4 BGI Genomics Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 BGI Genomics Co., Ltd. Recent Developments/Updates
9.13.6 BGI Genomics Co., Ltd. Competitive Strengths & Weaknesses
9.14 MGI Tech Co., Ltd.
9.14.1 MGI Tech Co., Ltd. Details
9.14.2 MGI Tech Co., Ltd. Major Business
9.14.3 MGI Tech Co., Ltd. NGS-based RNA-seq Product and Services
9.14.4 MGI Tech Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 MGI Tech Co., Ltd. Recent Developments/Updates
9.14.6 MGI Tech Co., Ltd. Competitive Strengths & Weaknesses
9.15 Novogene Co., Ltd.
9.15.1 Novogene Co., Ltd. Details
9.15.2 Novogene Co., Ltd. Major Business
9.15.3 Novogene Co., Ltd. NGS-based RNA-seq Product and Services
9.15.4 Novogene Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Novogene Co., Ltd. Recent Developments/Updates
9.15.6 Novogene Co., Ltd. Competitive Strengths & Weaknesses
9.16 Annoroad Gene Technology Co., Ltd.
9.16.1 Annoroad Gene Technology Co., Ltd. Details
9.16.2 Annoroad Gene Technology Co., Ltd. Major Business
9.16.3 Annoroad Gene Technology Co., Ltd. NGS-based RNA-seq Product and Services
9.16.4 Annoroad Gene Technology Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Annoroad Gene Technology Co., Ltd. Recent Developments/Updates
9.16.6 Annoroad Gene Technology Co., Ltd. Competitive Strengths & Weaknesses
9.17 Shanghai OE Biotech Co., Ltd.
9.17.1 Shanghai OE Biotech Co., Ltd. Details
9.17.2 Shanghai OE Biotech Co., Ltd. Major Business
9.17.3 Shanghai OE Biotech Co., Ltd. NGS-based RNA-seq Product and Services
9.17.4 Shanghai OE Biotech Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Shanghai OE Biotech Co., Ltd. Recent Developments/Updates
9.17.6 Shanghai OE Biotech Co., Ltd. Competitive Strengths & Weaknesses
9.18 LC-Bio Technology Co., Ltd.
9.18.1 LC-Bio Technology Co., Ltd. Details
9.18.2 LC-Bio Technology Co., Ltd. Major Business
9.18.3 LC-Bio Technology Co., Ltd. NGS-based RNA-seq Product and Services
9.18.4 LC-Bio Technology Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 LC-Bio Technology Co., Ltd. Recent Developments/Updates
9.18.6 LC-Bio Technology Co., Ltd. Competitive Strengths & Weaknesses
9.19 Guangzhou Gene Denovo Biotechnology Co., Ltd.
9.19.1 Guangzhou Gene Denovo Biotechnology Co., Ltd. Details
9.19.2 Guangzhou Gene Denovo Biotechnology Co., Ltd. Major Business
9.19.3 Guangzhou Gene Denovo Biotechnology Co., Ltd. NGS-based RNA-seq Product and Services
9.19.4 Guangzhou Gene Denovo Biotechnology Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Guangzhou Gene Denovo Biotechnology Co., Ltd. Recent Developments/Updates
9.19.6 Guangzhou Gene Denovo Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
9.20 Biomarker Technologies Corporation
9.20.1 Biomarker Technologies Corporation Details
9.20.2 Biomarker Technologies Corporation Major Business
9.20.3 Biomarker Technologies Corporation NGS-based RNA-seq Product and Services
9.20.4 Biomarker Technologies Corporation NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 Biomarker Technologies Corporation Recent Developments/Updates
9.20.6 Biomarker Technologies Corporation Competitive Strengths & Weaknesses
9.21 Berry Genomics Co., Ltd.
9.21.1 Berry Genomics Co., Ltd. Details
9.21.2 Berry Genomics Co., Ltd. Major Business
9.21.3 Berry Genomics Co., Ltd. NGS-based RNA-seq Product and Services
9.21.4 Berry Genomics Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 Berry Genomics Co., Ltd. Recent Developments/Updates
9.21.6 Berry Genomics Co., Ltd. Competitive Strengths & Weaknesses
9.22 CapitalBio Technology Co., Ltd.
9.22.1 CapitalBio Technology Co., Ltd. Details
9.22.2 CapitalBio Technology Co., Ltd. Major Business
9.22.3 CapitalBio Technology Co., Ltd. NGS-based RNA-seq Product and Services
9.22.4 CapitalBio Technology Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 CapitalBio Technology Co., Ltd. Recent Developments/Updates
9.22.6 CapitalBio Technology Co., Ltd. Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 NGS-based RNA-seq Industry Chain
10.2 NGS-based RNA-seq Upstream Analysis
10.3 NGS-based RNA-seq Midstream Analysis
10.4 NGS-based RNA-seq Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World NGS-based RNA-seq Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World NGS-based RNA-seq Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World NGS-based RNA-seq Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World NGS-based RNA-seq Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World NGS-based RNA-seq Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World NGS-based RNA-seq Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World NGS-based RNA-seq Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World NGS-based RNA-seq Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World NGS-based RNA-seq Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key NGS-based RNA-seq Players in 2025
Table 12. World NGS-based RNA-seq Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global NGS-based RNA-seq Company Evaluation Quadrant
Table 14. Head Office of Key NGS-based RNA-seq Players
Table 15. NGS-based RNA-seq Market: Company Product Type Footprint
Table 16. NGS-based RNA-seq Market: Company Product Application Footprint
Table 17. NGS-based RNA-seq Mergers & Acquisitions Activity
Table 18. United States VS China NGS-based RNA-seq Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China NGS-based RNA-seq Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based NGS-based RNA-seq Companies, Headquarters (States, Country)
Table 21. United States Based Companies NGS-based RNA-seq Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies NGS-based RNA-seq Revenue Market Share (2021-2026)
Table 23. China Based NGS-based RNA-seq Companies, Headquarters (Province, Country)
Table 24. China Based Companies NGS-based RNA-seq Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies NGS-based RNA-seq Revenue Market Share (2021-2026)
Table 26. Rest of World Based NGS-based RNA-seq Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies NGS-based RNA-seq Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies NGS-based RNA-seq Revenue Market Share (2021-2026)
Table 29. World NGS-based RNA-seq Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World NGS-based RNA-seq Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World NGS-based RNA-seq Market Size by Type (2027-2032) & (USD Million)
Table 32. World NGS-based RNA-seq Market Size by Library Preparation Method, (USD Million), 2021 & 2025 & 2032
Table 33. World NGS-based RNA-seq Market Size Value by Library Preparation Method (2021-2026) & (USD Million)
Table 34. World NGS-based RNA-seq Market Size by Library Preparation Method (2027-2032) & (USD Million)
Table 35. World NGS-based RNA-seq Market Size by Sequencing Depth per Sample, (USD Million), 2021 & 2025 & 2032
Table 36. World NGS-based RNA-seq Market Size Value by Sequencing Depth per Sample (2021-2026) & (USD Million)
Table 37. World NGS-based RNA-seq Market Size by Sequencing Depth per Sample (2027-2032) & (USD Million)
Table 38. World NGS-based RNA-seq Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World NGS-based RNA-seq Market Size by Application (2021-2026) & (USD Million)
Table 40. World NGS-based RNA-seq Market Size by Application (2027-2032) & (USD Million)
Table 41. Illumina, Inc. Basic Information, Manufacturing Base and Competitors
Table 42. Illumina, Inc. Major Business
Table 43. Illumina, Inc. NGS-based RNA-seq Product and Services
Table 44. Illumina, Inc. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Illumina, Inc. Recent Developments/Updates
Table 46. Illumina, Inc. Competitive Strengths & Weaknesses
Table 47. Thermo Fisher Scientific Inc. Basic Information, Manufacturing Base and Competitors
Table 48. Thermo Fisher Scientific Inc. Major Business
Table 49. Thermo Fisher Scientific Inc. NGS-based RNA-seq Product and Services
Table 50. Thermo Fisher Scientific Inc. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Thermo Fisher Scientific Inc. Recent Developments/Updates
Table 52. Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
Table 53. QIAGEN N.V. Basic Information, Manufacturing Base and Competitors
Table 54. QIAGEN N.V. Major Business
Table 55. QIAGEN N.V. NGS-based RNA-seq Product and Services
Table 56. QIAGEN N.V. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. QIAGEN N.V. Recent Developments/Updates
Table 58. QIAGEN N.V. Competitive Strengths & Weaknesses
Table 59. Takara Bio Inc. Basic Information, Manufacturing Base and Competitors
Table 60. Takara Bio Inc. Major Business
Table 61. Takara Bio Inc. NGS-based RNA-seq Product and Services
Table 62. Takara Bio Inc. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Takara Bio Inc. Recent Developments/Updates
Table 64. Takara Bio Inc. Competitive Strengths & Weaknesses
Table 65. Azenta, Inc. Basic Information, Manufacturing Base and Competitors
Table 66. Azenta, Inc. Major Business
Table 67. Azenta, Inc. NGS-based RNA-seq Product and Services
Table 68. Azenta, Inc. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Azenta, Inc. Recent Developments/Updates
Table 70. Azenta, Inc. Competitive Strengths & Weaknesses
Table 71. Eurofins Scientific SE Basic Information, Manufacturing Base and Competitors
Table 72. Eurofins Scientific SE Major Business
Table 73. Eurofins Scientific SE NGS-based RNA-seq Product and Services
Table 74. Eurofins Scientific SE NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Eurofins Scientific SE Recent Developments/Updates
Table 76. Eurofins Scientific SE Competitive Strengths & Weaknesses
Table 77. BGI Americas Corporation Basic Information, Manufacturing Base and Competitors
Table 78. BGI Americas Corporation Major Business
Table 79. BGI Americas Corporation NGS-based RNA-seq Product and Services
Table 80. BGI Americas Corporation NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. BGI Americas Corporation Recent Developments/Updates
Table 82. BGI Americas Corporation Competitive Strengths & Weaknesses
Table 83. Macrogen, Inc. Basic Information, Manufacturing Base and Competitors
Table 84. Macrogen, Inc. Major Business
Table 85. Macrogen, Inc. NGS-based RNA-seq Product and Services
Table 86. Macrogen, Inc. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Macrogen, Inc. Recent Developments/Updates
Table 88. Macrogen, Inc. Competitive Strengths & Weaknesses
Table 89. Ebiogen Inc. Basic Information, Manufacturing Base and Competitors
Table 90. Ebiogen Inc. Major Business
Table 91. Ebiogen Inc. NGS-based RNA-seq Product and Services
Table 92. Ebiogen Inc. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Ebiogen Inc. Recent Developments/Updates
Table 94. Ebiogen Inc. Competitive Strengths & Weaknesses
Table 95. Theragen Bio Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 96. Theragen Bio Co., Ltd. Major Business
Table 97. Theragen Bio Co., Ltd. NGS-based RNA-seq Product and Services
Table 98. Theragen Bio Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Theragen Bio Co., Ltd. Recent Developments/Updates
Table 100. Theragen Bio Co., Ltd. Competitive Strengths & Weaknesses
Table 101. Psomagen, Inc. Basic Information, Manufacturing Base and Competitors
Table 102. Psomagen, Inc. Major Business
Table 103. Psomagen, Inc. NGS-based RNA-seq Product and Services
Table 104. Psomagen, Inc. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Psomagen, Inc. Recent Developments/Updates
Table 106. Psomagen, Inc. Competitive Strengths & Weaknesses
Table 107. GeneMotions Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 108. GeneMotions Co., Ltd. Major Business
Table 109. GeneMotions Co., Ltd. NGS-based RNA-seq Product and Services
Table 110. GeneMotions Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. GeneMotions Co., Ltd. Recent Developments/Updates
Table 112. GeneMotions Co., Ltd. Competitive Strengths & Weaknesses
Table 113. BGI Genomics Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 114. BGI Genomics Co., Ltd. Major Business
Table 115. BGI Genomics Co., Ltd. NGS-based RNA-seq Product and Services
Table 116. BGI Genomics Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. BGI Genomics Co., Ltd. Recent Developments/Updates
Table 118. BGI Genomics Co., Ltd. Competitive Strengths & Weaknesses
Table 119. MGI Tech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 120. MGI Tech Co., Ltd. Major Business
Table 121. MGI Tech Co., Ltd. NGS-based RNA-seq Product and Services
Table 122. MGI Tech Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. MGI Tech Co., Ltd. Recent Developments/Updates
Table 124. MGI Tech Co., Ltd. Competitive Strengths & Weaknesses
Table 125. Novogene Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 126. Novogene Co., Ltd. Major Business
Table 127. Novogene Co., Ltd. NGS-based RNA-seq Product and Services
Table 128. Novogene Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Novogene Co., Ltd. Recent Developments/Updates
Table 130. Novogene Co., Ltd. Competitive Strengths & Weaknesses
Table 131. Annoroad Gene Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 132. Annoroad Gene Technology Co., Ltd. Major Business
Table 133. Annoroad Gene Technology Co., Ltd. NGS-based RNA-seq Product and Services
Table 134. Annoroad Gene Technology Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Annoroad Gene Technology Co., Ltd. Recent Developments/Updates
Table 136. Annoroad Gene Technology Co., Ltd. Competitive Strengths & Weaknesses
Table 137. Shanghai OE Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 138. Shanghai OE Biotech Co., Ltd. Major Business
Table 139. Shanghai OE Biotech Co., Ltd. NGS-based RNA-seq Product and Services
Table 140. Shanghai OE Biotech Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Shanghai OE Biotech Co., Ltd. Recent Developments/Updates
Table 142. Shanghai OE Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 143. LC-Bio Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 144. LC-Bio Technology Co., Ltd. Major Business
Table 145. LC-Bio Technology Co., Ltd. NGS-based RNA-seq Product and Services
Table 146. LC-Bio Technology Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. LC-Bio Technology Co., Ltd. Recent Developments/Updates
Table 148. LC-Bio Technology Co., Ltd. Competitive Strengths & Weaknesses
Table 149. Guangzhou Gene Denovo Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 150. Guangzhou Gene Denovo Biotechnology Co., Ltd. Major Business
Table 151. Guangzhou Gene Denovo Biotechnology Co., Ltd. NGS-based RNA-seq Product and Services
Table 152. Guangzhou Gene Denovo Biotechnology Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Guangzhou Gene Denovo Biotechnology Co., Ltd. Recent Developments/Updates
Table 154. Guangzhou Gene Denovo Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
Table 155. Biomarker Technologies Corporation Basic Information, Manufacturing Base and Competitors
Table 156. Biomarker Technologies Corporation Major Business
Table 157. Biomarker Technologies Corporation NGS-based RNA-seq Product and Services
Table 158. Biomarker Technologies Corporation NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. Biomarker Technologies Corporation Recent Developments/Updates
Table 160. Biomarker Technologies Corporation Competitive Strengths & Weaknesses
Table 161. Berry Genomics Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 162. Berry Genomics Co., Ltd. Major Business
Table 163. Berry Genomics Co., Ltd. NGS-based RNA-seq Product and Services
Table 164. Berry Genomics Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Berry Genomics Co., Ltd. Recent Developments/Updates
Table 166. Berry Genomics Co., Ltd. Competitive Strengths & Weaknesses
Table 167. CapitalBio Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 168. CapitalBio Technology Co., Ltd. Major Business
Table 169. CapitalBio Technology Co., Ltd. NGS-based RNA-seq Product and Services
Table 170. CapitalBio Technology Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. CapitalBio Technology Co., Ltd. Recent Developments/Updates
Table 172. CapitalBio Technology Co., Ltd. Competitive Strengths & Weaknesses
Table 173. Global Key Players of NGS-based RNA-seq Upstream (Raw Materials)
Table 174. Global NGS-based RNA-seq Typical Customers
Table 1. World NGS-based RNA-seq Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World NGS-based RNA-seq Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World NGS-based RNA-seq Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World NGS-based RNA-seq Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World NGS-based RNA-seq Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World NGS-based RNA-seq Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World NGS-based RNA-seq Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World NGS-based RNA-seq Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World NGS-based RNA-seq Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key NGS-based RNA-seq Players in 2025
Table 12. World NGS-based RNA-seq Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global NGS-based RNA-seq Company Evaluation Quadrant
Table 14. Head Office of Key NGS-based RNA-seq Players
Table 15. NGS-based RNA-seq Market: Company Product Type Footprint
Table 16. NGS-based RNA-seq Market: Company Product Application Footprint
Table 17. NGS-based RNA-seq Mergers & Acquisitions Activity
Table 18. United States VS China NGS-based RNA-seq Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China NGS-based RNA-seq Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based NGS-based RNA-seq Companies, Headquarters (States, Country)
Table 21. United States Based Companies NGS-based RNA-seq Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies NGS-based RNA-seq Revenue Market Share (2021-2026)
Table 23. China Based NGS-based RNA-seq Companies, Headquarters (Province, Country)
Table 24. China Based Companies NGS-based RNA-seq Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies NGS-based RNA-seq Revenue Market Share (2021-2026)
Table 26. Rest of World Based NGS-based RNA-seq Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies NGS-based RNA-seq Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies NGS-based RNA-seq Revenue Market Share (2021-2026)
Table 29. World NGS-based RNA-seq Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World NGS-based RNA-seq Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World NGS-based RNA-seq Market Size by Type (2027-2032) & (USD Million)
Table 32. World NGS-based RNA-seq Market Size by Library Preparation Method, (USD Million), 2021 & 2025 & 2032
Table 33. World NGS-based RNA-seq Market Size Value by Library Preparation Method (2021-2026) & (USD Million)
Table 34. World NGS-based RNA-seq Market Size by Library Preparation Method (2027-2032) & (USD Million)
Table 35. World NGS-based RNA-seq Market Size by Sequencing Depth per Sample, (USD Million), 2021 & 2025 & 2032
Table 36. World NGS-based RNA-seq Market Size Value by Sequencing Depth per Sample (2021-2026) & (USD Million)
Table 37. World NGS-based RNA-seq Market Size by Sequencing Depth per Sample (2027-2032) & (USD Million)
Table 38. World NGS-based RNA-seq Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World NGS-based RNA-seq Market Size by Application (2021-2026) & (USD Million)
Table 40. World NGS-based RNA-seq Market Size by Application (2027-2032) & (USD Million)
Table 41. Illumina, Inc. Basic Information, Manufacturing Base and Competitors
Table 42. Illumina, Inc. Major Business
Table 43. Illumina, Inc. NGS-based RNA-seq Product and Services
Table 44. Illumina, Inc. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Illumina, Inc. Recent Developments/Updates
Table 46. Illumina, Inc. Competitive Strengths & Weaknesses
Table 47. Thermo Fisher Scientific Inc. Basic Information, Manufacturing Base and Competitors
Table 48. Thermo Fisher Scientific Inc. Major Business
Table 49. Thermo Fisher Scientific Inc. NGS-based RNA-seq Product and Services
Table 50. Thermo Fisher Scientific Inc. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Thermo Fisher Scientific Inc. Recent Developments/Updates
Table 52. Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
Table 53. QIAGEN N.V. Basic Information, Manufacturing Base and Competitors
Table 54. QIAGEN N.V. Major Business
Table 55. QIAGEN N.V. NGS-based RNA-seq Product and Services
Table 56. QIAGEN N.V. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. QIAGEN N.V. Recent Developments/Updates
Table 58. QIAGEN N.V. Competitive Strengths & Weaknesses
Table 59. Takara Bio Inc. Basic Information, Manufacturing Base and Competitors
Table 60. Takara Bio Inc. Major Business
Table 61. Takara Bio Inc. NGS-based RNA-seq Product and Services
Table 62. Takara Bio Inc. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Takara Bio Inc. Recent Developments/Updates
Table 64. Takara Bio Inc. Competitive Strengths & Weaknesses
Table 65. Azenta, Inc. Basic Information, Manufacturing Base and Competitors
Table 66. Azenta, Inc. Major Business
Table 67. Azenta, Inc. NGS-based RNA-seq Product and Services
Table 68. Azenta, Inc. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Azenta, Inc. Recent Developments/Updates
Table 70. Azenta, Inc. Competitive Strengths & Weaknesses
Table 71. Eurofins Scientific SE Basic Information, Manufacturing Base and Competitors
Table 72. Eurofins Scientific SE Major Business
Table 73. Eurofins Scientific SE NGS-based RNA-seq Product and Services
Table 74. Eurofins Scientific SE NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Eurofins Scientific SE Recent Developments/Updates
Table 76. Eurofins Scientific SE Competitive Strengths & Weaknesses
Table 77. BGI Americas Corporation Basic Information, Manufacturing Base and Competitors
Table 78. BGI Americas Corporation Major Business
Table 79. BGI Americas Corporation NGS-based RNA-seq Product and Services
Table 80. BGI Americas Corporation NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. BGI Americas Corporation Recent Developments/Updates
Table 82. BGI Americas Corporation Competitive Strengths & Weaknesses
Table 83. Macrogen, Inc. Basic Information, Manufacturing Base and Competitors
Table 84. Macrogen, Inc. Major Business
Table 85. Macrogen, Inc. NGS-based RNA-seq Product and Services
Table 86. Macrogen, Inc. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Macrogen, Inc. Recent Developments/Updates
Table 88. Macrogen, Inc. Competitive Strengths & Weaknesses
Table 89. Ebiogen Inc. Basic Information, Manufacturing Base and Competitors
Table 90. Ebiogen Inc. Major Business
Table 91. Ebiogen Inc. NGS-based RNA-seq Product and Services
Table 92. Ebiogen Inc. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Ebiogen Inc. Recent Developments/Updates
Table 94. Ebiogen Inc. Competitive Strengths & Weaknesses
Table 95. Theragen Bio Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 96. Theragen Bio Co., Ltd. Major Business
Table 97. Theragen Bio Co., Ltd. NGS-based RNA-seq Product and Services
Table 98. Theragen Bio Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Theragen Bio Co., Ltd. Recent Developments/Updates
Table 100. Theragen Bio Co., Ltd. Competitive Strengths & Weaknesses
Table 101. Psomagen, Inc. Basic Information, Manufacturing Base and Competitors
Table 102. Psomagen, Inc. Major Business
Table 103. Psomagen, Inc. NGS-based RNA-seq Product and Services
Table 104. Psomagen, Inc. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Psomagen, Inc. Recent Developments/Updates
Table 106. Psomagen, Inc. Competitive Strengths & Weaknesses
Table 107. GeneMotions Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 108. GeneMotions Co., Ltd. Major Business
Table 109. GeneMotions Co., Ltd. NGS-based RNA-seq Product and Services
Table 110. GeneMotions Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. GeneMotions Co., Ltd. Recent Developments/Updates
Table 112. GeneMotions Co., Ltd. Competitive Strengths & Weaknesses
Table 113. BGI Genomics Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 114. BGI Genomics Co., Ltd. Major Business
Table 115. BGI Genomics Co., Ltd. NGS-based RNA-seq Product and Services
Table 116. BGI Genomics Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. BGI Genomics Co., Ltd. Recent Developments/Updates
Table 118. BGI Genomics Co., Ltd. Competitive Strengths & Weaknesses
Table 119. MGI Tech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 120. MGI Tech Co., Ltd. Major Business
Table 121. MGI Tech Co., Ltd. NGS-based RNA-seq Product and Services
Table 122. MGI Tech Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. MGI Tech Co., Ltd. Recent Developments/Updates
Table 124. MGI Tech Co., Ltd. Competitive Strengths & Weaknesses
Table 125. Novogene Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 126. Novogene Co., Ltd. Major Business
Table 127. Novogene Co., Ltd. NGS-based RNA-seq Product and Services
Table 128. Novogene Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Novogene Co., Ltd. Recent Developments/Updates
Table 130. Novogene Co., Ltd. Competitive Strengths & Weaknesses
Table 131. Annoroad Gene Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 132. Annoroad Gene Technology Co., Ltd. Major Business
Table 133. Annoroad Gene Technology Co., Ltd. NGS-based RNA-seq Product and Services
Table 134. Annoroad Gene Technology Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Annoroad Gene Technology Co., Ltd. Recent Developments/Updates
Table 136. Annoroad Gene Technology Co., Ltd. Competitive Strengths & Weaknesses
Table 137. Shanghai OE Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 138. Shanghai OE Biotech Co., Ltd. Major Business
Table 139. Shanghai OE Biotech Co., Ltd. NGS-based RNA-seq Product and Services
Table 140. Shanghai OE Biotech Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Shanghai OE Biotech Co., Ltd. Recent Developments/Updates
Table 142. Shanghai OE Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 143. LC-Bio Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 144. LC-Bio Technology Co., Ltd. Major Business
Table 145. LC-Bio Technology Co., Ltd. NGS-based RNA-seq Product and Services
Table 146. LC-Bio Technology Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. LC-Bio Technology Co., Ltd. Recent Developments/Updates
Table 148. LC-Bio Technology Co., Ltd. Competitive Strengths & Weaknesses
Table 149. Guangzhou Gene Denovo Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 150. Guangzhou Gene Denovo Biotechnology Co., Ltd. Major Business
Table 151. Guangzhou Gene Denovo Biotechnology Co., Ltd. NGS-based RNA-seq Product and Services
Table 152. Guangzhou Gene Denovo Biotechnology Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Guangzhou Gene Denovo Biotechnology Co., Ltd. Recent Developments/Updates
Table 154. Guangzhou Gene Denovo Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
Table 155. Biomarker Technologies Corporation Basic Information, Manufacturing Base and Competitors
Table 156. Biomarker Technologies Corporation Major Business
Table 157. Biomarker Technologies Corporation NGS-based RNA-seq Product and Services
Table 158. Biomarker Technologies Corporation NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. Biomarker Technologies Corporation Recent Developments/Updates
Table 160. Biomarker Technologies Corporation Competitive Strengths & Weaknesses
Table 161. Berry Genomics Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 162. Berry Genomics Co., Ltd. Major Business
Table 163. Berry Genomics Co., Ltd. NGS-based RNA-seq Product and Services
Table 164. Berry Genomics Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Berry Genomics Co., Ltd. Recent Developments/Updates
Table 166. Berry Genomics Co., Ltd. Competitive Strengths & Weaknesses
Table 167. CapitalBio Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 168. CapitalBio Technology Co., Ltd. Major Business
Table 169. CapitalBio Technology Co., Ltd. NGS-based RNA-seq Product and Services
Table 170. CapitalBio Technology Co., Ltd. NGS-based RNA-seq Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. CapitalBio Technology Co., Ltd. Recent Developments/Updates
Table 172. CapitalBio Technology Co., Ltd. Competitive Strengths & Weaknesses
Table 173. Global Key Players of NGS-based RNA-seq Upstream (Raw Materials)
Table 174. Global NGS-based RNA-seq Typical Customers
LIST OF FIGURES
Figure 1. NGS-based RNA-seq Picture
Figure 2. World NGS-based RNA-seq Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World NGS-based RNA-seq Total Revenue (2021-2032) & (USD Million)
Figure 4. World NGS-based RNA-seq Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World NGS-based RNA-seq Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company NGS-based RNA-seq Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company NGS-based RNA-seq Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company NGS-based RNA-seq Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company NGS-based RNA-seq Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company NGS-based RNA-seq Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company NGS-based RNA-seq Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company NGS-based RNA-seq Revenue (2021-2032) & (USD Million)
Figure 13. NGS-based RNA-seq Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World NGS-based RNA-seq Consumption Value (2021-2032) & (USD Million)
Figure 16. World NGS-based RNA-seq Consumption Value Market Share by Region (2021-2032)
Figure 17. United States NGS-based RNA-seq Consumption Value (2021-2032) & (USD Million)
Figure 18. China NGS-based RNA-seq Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe NGS-based RNA-seq Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan NGS-based RNA-seq Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea NGS-based RNA-seq Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN NGS-based RNA-seq Consumption Value (2021-2032) & (USD Million)
Figure 23. India NGS-based RNA-seq Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of NGS-based RNA-seq by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for NGS-based RNA-seq Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for NGS-based RNA-seq Markets in 2025
Figure 27. United States VS China: NGS-based RNA-seq Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: NGS-based RNA-seq Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World NGS-based RNA-seq Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World NGS-based RNA-seq Market Size Market Share by Type in 2025
Figure 31. Whole Transcriptome Sequencing
Figure 32. Targeted RNA Sequencing
Figure 33. Small RNA Sequencing
Figure 34. World NGS-based RNA-seq Market Size Market Share by Type (2021-2032)
Figure 35. World NGS-based RNA-seq Market Size by Library Preparation Method, (USD Million), 2021 & 2025 & 2032
Figure 36. World NGS-based RNA-seq Market Size Market Share by Library Preparation Method in 2025
Figure 37. Poly(A) Enrichment-based Sequencing
Figure 38. rRNA Depletion-based Sequencing
Figure 39. Capture and Amplicon-based Sequencing
Figure 40. World NGS-based RNA-seq Market Size Market Share by Library Preparation Method (2021-2032)
Figure 41. World NGS-based RNA-seq Market Size by Sequencing Depth per Sample, (USD Million), 2021 & 2025 & 2032
Figure 42. World NGS-based RNA-seq Market Size Market Share by Sequencing Depth per Sample in 2025
Figure 43. Low-depth(≤20 Million Reads)
Figure 44. Medium-depth(>20–100 Million Reads)
Figure 45. High-depth(>100 Million Reads)
Figure 46. World NGS-based RNA-seq Market Size Market Share by Sequencing Depth per Sample (2021-2032)
Figure 47. World NGS-based RNA-seq Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World NGS-based RNA-seq Market Size Market Share by Application in 2025
Figure 49. Gene Expression Profiling
Figure 50. Biomarker and Disease Research
Figure 51. Fusion, Splicing and Transcript Variant Analysis
Figure 52. Other
Figure 53. World NGS-based RNA-seq Market Size Market Share by Application (2021-2032)
Figure 54. NGS-based RNA-seq Industrial Chain
Figure 55. Methodology
Figure 56. Research Process and Data Source
Figure 1. NGS-based RNA-seq Picture
Figure 2. World NGS-based RNA-seq Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World NGS-based RNA-seq Total Revenue (2021-2032) & (USD Million)
Figure 4. World NGS-based RNA-seq Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World NGS-based RNA-seq Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company NGS-based RNA-seq Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company NGS-based RNA-seq Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company NGS-based RNA-seq Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company NGS-based RNA-seq Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company NGS-based RNA-seq Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company NGS-based RNA-seq Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company NGS-based RNA-seq Revenue (2021-2032) & (USD Million)
Figure 13. NGS-based RNA-seq Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World NGS-based RNA-seq Consumption Value (2021-2032) & (USD Million)
Figure 16. World NGS-based RNA-seq Consumption Value Market Share by Region (2021-2032)
Figure 17. United States NGS-based RNA-seq Consumption Value (2021-2032) & (USD Million)
Figure 18. China NGS-based RNA-seq Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe NGS-based RNA-seq Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan NGS-based RNA-seq Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea NGS-based RNA-seq Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN NGS-based RNA-seq Consumption Value (2021-2032) & (USD Million)
Figure 23. India NGS-based RNA-seq Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of NGS-based RNA-seq by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for NGS-based RNA-seq Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for NGS-based RNA-seq Markets in 2025
Figure 27. United States VS China: NGS-based RNA-seq Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: NGS-based RNA-seq Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World NGS-based RNA-seq Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World NGS-based RNA-seq Market Size Market Share by Type in 2025
Figure 31. Whole Transcriptome Sequencing
Figure 32. Targeted RNA Sequencing
Figure 33. Small RNA Sequencing
Figure 34. World NGS-based RNA-seq Market Size Market Share by Type (2021-2032)
Figure 35. World NGS-based RNA-seq Market Size by Library Preparation Method, (USD Million), 2021 & 2025 & 2032
Figure 36. World NGS-based RNA-seq Market Size Market Share by Library Preparation Method in 2025
Figure 37. Poly(A) Enrichment-based Sequencing
Figure 38. rRNA Depletion-based Sequencing
Figure 39. Capture and Amplicon-based Sequencing
Figure 40. World NGS-based RNA-seq Market Size Market Share by Library Preparation Method (2021-2032)
Figure 41. World NGS-based RNA-seq Market Size by Sequencing Depth per Sample, (USD Million), 2021 & 2025 & 2032
Figure 42. World NGS-based RNA-seq Market Size Market Share by Sequencing Depth per Sample in 2025
Figure 43. Low-depth(≤20 Million Reads)
Figure 44. Medium-depth(>20–100 Million Reads)
Figure 45. High-depth(>100 Million Reads)
Figure 46. World NGS-based RNA-seq Market Size Market Share by Sequencing Depth per Sample (2021-2032)
Figure 47. World NGS-based RNA-seq Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World NGS-based RNA-seq Market Size Market Share by Application in 2025
Figure 49. Gene Expression Profiling
Figure 50. Biomarker and Disease Research
Figure 51. Fusion, Splicing and Transcript Variant Analysis
Figure 52. Other
Figure 53. World NGS-based RNA-seq Market Size Market Share by Application (2021-2032)
Figure 54. NGS-based RNA-seq Industrial Chain
Figure 55. Methodology
Figure 56. Research Process and Data Source
